NCT00655343 - Acute Graft-Versus-Host Disease (aGvHD) Prophylaxis With ATG-Fresenius in Matched Unrelated Donor-Stem Cell Transplantation (MUD-SCT) | Biotech Hunter

Enrollment

202

Participants

Timeline

Start Date

February 28, 2003

Primary Completion Date

March 31, 2007

Study Completion Date

March 31, 2009

Conditions

Graft vs Host Disease

Interventions

DRUG

ATG-Fresenius S

"20 mg rabbit immunoglobulin (IgG) in 1 ml of sterile solution~20 mg/kg body weight per day diluted in 500 ml physiological saline, slow intravenous infusion at days -3, -2, -1 prior to transplantation"

Trial Locations (1)

79110

Universität Freiburg, Medizinische Klinik, Abteilung Innere Medizin I, Hämatologie/Onkologie, Freiburg im Breisgau